Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision.
Hannah BowerThomas FrisellDaniela di GiuseppeBénédicte DelcoigneGerd-Marfie AhleniusEva BaecklundKaterina ChatzidionysiouNils FelteliusHelena Forsblad-d'EliaAlf KastbomLars KlareskogElisabet LindqvistUlf LindströmCarl TuressonChristopher SjöwallJohan Asklingnull nullPublished in: RMD open (2021)
Patients with IJD are at increased risk of serious COVID-19 outcomes, which may partially be explained by medical conditions other than IJD per se. The SARS-CoV-2 pandemic has exerted measurable effects on aspects of rheumatology care provision demonstrated, the future impact of which will need to be assessed.